Monday, February 26, 2018
Find a Lyme doctor, and latest updates in the 'Lyme wars' between ILADS and IDSA
Wednesday, February 14, 2018
Oxford Diagnostics Laboratories Imugen test for Lyme and Co-Infections
Over 25 years ago, a small team of Massachusetts Department of Public Health State Laboratory employees, working alongside leading clinicians in the emerging area of Lyme disease, recognized that the diagnostic tools available to physicians and laboratories were limited. This motivated team knew patients deserved better and in 1989 founded Imugen. The roots of Imugen began in providing fast, trusted and accessible testing for evidence of Borrelia burgdorferi infection, the infection that causes Lyme disease. Over time, these founding principles have been applied to other tick-borne infections and have grown to represent a menu of Imugen testing services.
Innovation remains embedded in Imugen's testing services, with progressive PCR and serology test offerings. This comprehensive testing including PCR and serology may offer a greater opportunity to detect evidence of tick-borne infection.* Other innovations include a robust, internal database of infection positivity rates by region, the identification of Borrelia miyamotoi infection in the first clinical case in the United States in 2012 and, most recently, the completion of a three-year clinical trial to evaluate a testing algorithm for detecting Babesia microti in donated blood.
In 2016, Imugen became part of the Oxford Immunotec family through an acquisition. Testing services are being expanded beyond the Northeast to provide clinicians across the United States with comprehensive testing solutions for tick-borne infections.
Thursday, February 1, 2018
Blood test finds toxic Alzheimer's proteins
-Bob
Blood test finds toxic Alzheimer's proteins - http://www.bbc.co.uk/news/health-42878721
Tuesday, January 23, 2018
Researchers are worried that a brain illness known as 'zombie deer' disease may start infecting humans
Canadian researchers are concerned the disease could potentially start to infect humans who eat deer, elk, moose, or other members of the animal family that carry misfolded proteins.
Sunday, January 21, 2018
Class-action suit against the French government filed by Lyme patients
IN FRANCE – 300 people with Lyme disease will file criminal complaints in early January 2018 against the State, the National Agency
for the Safety of Medicines and Health Products (ANSM) and the National Reference Center (CNR) in Strasbourg for influence peddling,
abuse of company or government assets, concealment of abuse of government or company assets,endangering the lives of others,
violation of the principle of independence of experts and conflict of interests.
Monday, January 8, 2018
The antioxidant Ebselen prevents neurotoxicity
The antioxidant Ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease. - PubMed - NCBI
Thursday, January 4, 2018
Weird EYE problems related to Lyme and Bartonella infection
Saturday, December 16, 2017
IVIG and small fiber neuropathy
However, for large, myelinated fibers that become demyelinated, these lesions can be reversed with IVIG treatment.
Interestingly, lots of Lyme patients have both.
IVIG can get approved by insurance as a treatment for demyelination (as initially diagnosed with EMG-NCV studies) but so far insurance will not approve IVIG for biopsy proven (simple punch skin biopsy) small fiber neuropathy.
Because Lyme patients usually have both, treatment gets approved to treat the large fiber neuropathy but lo and behold, the small fiber stuff (pain and dysautonomia) can also clear.
So finally the attached article demonstrates this. Note that it comes from Harvard and does not mention Lyme disease- that is what got it published.
This is especially important as the EMG-NCV studies will not detect small fiber problems at all, and more importantly, will miss possibly half the cases of large fiber neuropathy, thus preventing insurance coverage and needed treatment. In contrast, skin biopsies specifically stained to see small fibers picks up a much higher percentage of cases, offering hope for a more sensitive way to get diagnosed and treated.
Whether this will be enough to get insurance to cover IVIG for small fiber neuropathy is yet to be seen.
Please share this with all the docs (Barbara- can you send this out to the ILADS group? Put it on the website?) and especially the neurologists you may know.
Thanks!
Dr. B
Joseph J. Burrascano Jr. M.D.
Water Mill, NY, USA
Sent from my LapTop
Thursday, December 14, 2017
Antitrust Lawsuit Pushes Chronic Lyme Disease into Health Care Limelight
Thursday, November 30, 2017
Mayo Clinic Trained Physician - Dr Miller Speaks out about Lyme Disease
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|